NASH and Nutritional Therapy
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Tokyo :
Springer Tokyo
2005.
|
| Colección: | Springer eBooks.
|
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b32896852*spi |
Tabla de Contenidos:
- Nonalcoholic Fatty Liver (NAFL): Overview
- Role of Leptin in Pathogenesis of NASH
- Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis
- Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH)
- Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH
- Clinical Features of Patients with Nonalcoholic Fatty Liver Disease
- Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH)
- Mammalian Target of Rapamycin (mTOR)
- Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis
- Nutritional Therapy in Patients with Liver Cirrhosis.
